US equities |
NVDA $238.90 ▲+2.12% SPCX $171.09 ▲+7.63% MU $1,063.96 ▼-1.02% TSLA $378.73 ▲+2.20% WBD $30.95 ▲+0.03% MSFT $525.18 ▲+1.48% AAPL $332.89 ▼-0.24% META $741.90 ▲+1.90%
FinancialContent

Zomedica Corp. Common Shares (NY:ZOM)

0.0973 UNCHANGED
Last Price Updated: 8:00 PM EST, Mar 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Zomedica Corp. Common Shares

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
News headline image
Earnings Scheduled For August 10, 2023 ↗
Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report quarterly loss at $0.39 per share on revenue of $1.60 million. 
Via Benzinga
News headline image
Why Shares of Zomedica Were Zooming Monday ↗
Investors bought back into the stock after it fell to its lowest point in two months. 
Via The Motley Fool
News headline image
Zomedica to Present at Sidoti Virtual Investor Conference August 16-17
Via ACCESSWIRE
News headline image
Zomedica to Host Second Quarter Financial Results Call on August 10
Via ACCESSWIRE
News headline image
RedChip Launches 'Small Stocks, Big Money' Podcast
Via ACCESSWIRE
News headline image
Zomedica Launches Revolutionary TRUVIEW(TM) Digital Microscope with Advanced Optics, Automated Slide Preparation, and Telepathology Services
Via ACCESSWIRE
News headline image
Zomedica to Participate in the Lytham Partners Spring 2023 Investor Conference
Via ACCESSWIRE
News headline image
The 7 Most Promising Penny Stocks to Buy in May 2023 ↗
Although extremely low-priced securities often present high risk, these are the most promising penny stocks to buy in May. 
Via InvestorPlace
News headline image
Zomedica Announces Record First Quarter 2023 Financial Results: Revenue up 45% to $5.5 Million; Strong 70% Gross Margin & $147.5 Million in Liquidity
Via ACCESSWIRE
News headline image
Earnings Scheduled For May 11, 2023 ↗
Companies Reporting Before The Bell • Takeda Pharmaceutical (NYSE:TAK) is likely to report earnings for its fourth quarter. • Exela Technologies (NASDAQ:XELA) is expected to report earnings for its... 
Via Benzinga
News headline image
Zomedica Exercises Option to Acquire Structured Monitoring Products
Via ACCESSWIRE
News headline image
Zomedica to Host First Quarter Financial Results Call on May 11
Via ACCESSWIRE
News headline image
7 Small-Cap Biotech Stocks with Massive Potential ↗
Although small-cap biotech stocks present high risks, if they hit one out of the park, the rewards can be astronomical. 
Via InvestorPlace
News headline image
Zomedica to Present at H.C. Wainwright 24th Annual Global Investment Conference
Via ACCESSWIRE
News headline image
7 Best Penny Stocks Under $3 to Buy in April ↗
If you have the audacity to consider ultra-speculative opportunities, these ideas for best penny stocks under $3 might be appealing. 
Via InvestorPlace
News headline image
Zomedica Corp. Interview to Air on Bloomberg U.S. on the RedChip Money Report(R)
Via ACCESSWIRE
News headline image
Zomedica Appoints New Chief Financial Officer
Via ACCESSWIRE
News headline image
Zomedica Corporation Reports 2022 Results: $18.9 Million Revenue; 72% Gross Margin & $156 Million in Liquidity - Revenue up 361% from 2021 through combination of acquisitions and organic growth
Via ACCESSWIRE
News headline image
Zomedica to Host Fourth Quarter and Fiscal Year 2022 Financial Results Call on March 15
Via ACCESSWIRE
News headline image
Zomedica Reports Preliminary Results for the Fourth Quarter and Full Year 2022
Via ACCESSWIRE
News headline image
Earnings Scheduled For March 15, 2023 ↗
Companies Reporting Before The Bell • Sportradar Gr (NASDAQ:SRAD) is estimated to report quarterly earnings at $0.04 per share on revenue of $208.09 million. 
Via Benzinga
News headline image
Zomedica Interview To Air on Bloomberg U.S. on the RedChip Money Report(R)
Via ACCESSWIRE
News headline image
RedChip CEO Dave Gentry Invited to Join Forbes Business Council
Via ACCESSWIRE
News headline image
Zomedica to Participate in the Lytham Partners Investor Select Conference
Via ACCESSWIRE
News headline image
PRTY Stock Alert: NYSE Halts Trading in Party City Amid Bankruptcy News ↗
Party City (PRTY) stock halted trading this morning after the retail company filed for Chapter 11 bankruptcy protection. 
Via InvestorPlace
News headline image
Why Is Zomedica (ZOM) Stock Up Today? ↗
Zomedica (ZOM) stock is on the rise Wednesday after the company signed a strategic restructuring agreement with Qorvo Biotechnologies. 
Via InvestorPlace
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗
We're starting the day with a breakdown of the biggest pre-market stock movers traders will want to watch on Wednesday morning! 
Via InvestorPlace
News headline image
Zomedica to Take Control of New Assay Development and Manufacturing of TRUFORMA Product Line through Long-Term Licensing Agreement with Qorvo Biotechnologies
Via ACCESSWIRE
News headline image
Zomedica Expands Relationship with Structured Medical Products and Begins Commercializing VetGuardian Wireless Monitors
Via ACCESSWIRE
News headline image
Zomedica to Present at Sidoti Virtual Investor Conference January 18-19
Via ACCESSWIRE
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >